Context Involvement of the pituitary gland in SARS-CoV-2 infection has been clinically
suggested by pituitary hormone deficiency in severe COVID-19 cases, by altered serum …

Abstract Although coronavirus disease 2019 (COVID-19) mainly involves the lungs, it also
affects many systems. The hypothalamic/pituitary axis is vulnerable to hypoxia …

There is increased interest related to the impact of coronavirus disease 19 (COVID-19) on
the endocrine system and in particular on the pituitary gland. Over the course of the severe …

Introduction Angiotensin-converting enzyme 2 (ACE2) is the receptor of severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2). The effects of SARS-CoV-2 on normal …

Background Despite COVID-19 being identified as severe respiratory viral infection,
progressively many relevant endocrine manifestations have been reported greatly …

Altered circulating hormone and metabolite levels have been reported during and post-
COVID-19. Yet, studies of gene expression at the tissue level capable of identifying the …

SARS-CoV-2 may affect the hypothalamic-pituitary axis and pituitary dysfunction may occur.
Therefore, we investigated neuroendocrine changes, in particular, secondary adrenal …

Highlights What are the main findings? COVID-19 may lead to sequelae extending beyond
the acute phase of infection, characterized by fatigue and cognitive impairments, forming a …

Purpose The coronavirus disease 2019 (COVID-19) pandemic is widely believed to have
had a major impact on the care of patients with pituitary disease. The virus itself may directly …

This review is aimed at illustrating and discussing the neuroimmune endocrinological
aspects of the SARS-CoV-2 infection in light of the studies on this topic that have so far …